A scrutiny of circulating microRNA biomarkers for drug-induced tubular and glomerular injury in rats
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 415, 26-36
Abstract
No abstract availableKeywords
Funding Information
- Food Safety Commission, Cabinet Office, Government of Japan
This publication has 43 references indexed in Scilit:
- Circulating microRNAs: Association with disease and potential use as biomarkersCritical Reviews in Oncology/Hematology, 2011
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaProceedings of the National Academy of Sciences, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Performance of Novel Kidney Biomarkers in Preclinical Toxicity StudiesToxicological Sciences, 2010
- Circulating microRNAs, potential biomarkers for drug-induced liver injuryProceedings of the National Academy of Sciences, 2009
- Detection of microRNA Expression in Human Peripheral Blood MicrovesiclesPLOS ONE, 2008
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin CClinical Journal of the American Society of Nephrology, 2008
- Identifying genetic risk factors for serious adverse drug reactions: current progress and challengesNature Reviews Drug Discovery, 2007
- The evolution of gene regulation by transcription factors and microRNAsNature Reviews Genetics, 2007